• SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States

    Jun 1, 2024, 00:00

  • EE454 Economic Burden of Mild and Moderate Asthma in Adult Patients From Public Health Institutions Perspective in Mexico

    Jun 1, 2024, 00:00

  • RWD163 Medication Adherence and Persistence on Selumetinib Treatment in Pediatric Patients: A US Claims Database Analysis

    Jun 1, 2024, 00:00

  • HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines

    Jun 1, 2024, 00:00

  • HPR133 Clinical Benefits of the Accelerated Approval Program in Oncology

    Jun 1, 2024, 00:00

  • PCR187 Continuous Glucose Monitoring Adherence and Healthcare Costs in Adult Patients With Diabetes: Examining the Impact of Device Sourcing

    Jun 1, 2024, 00:00

  • CO143 Clinical Outcomes of First-Line (1L) Treatments (Txs) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • HPR33 Short- and Long-Term Impacts of the National Essential Medicines Policy on Drug in Rural China

    Jun 1, 2024, 00:00

  • RWD110 Group-Based Trajectory Modeling to Identify Longitudinal Patterns of Adherence to Oral Antidiabetic Medication in Older Adults on Concomitant Triple Therapy (Oral Antidiabetics, RAS Antagonists, Statins)

    Jun 1, 2024, 00:00

  • HTA60 What Utilization Management Strategies Does ICER Recommend to US Payers and Policy-Makers to Manage Uncertainty with Gene Therapies?

    Jun 1, 2024, 00:00

  • PCR46 A Qualitative Exploration of Patient and Healthcare Provider Perspectives on Oxybate Treatments for Narcolepsy

    Jun 1, 2024, 00:00

  • MSR72 An Evaluation of the Rayyan Artificial Intelligence Tool for Systematic Literature Review Screening

    Jun 1, 2024, 00:00

  • EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada

    Jun 1, 2024, 00:00

  • PCR243 Examining the Relevance of the SF-36v2 for Assessment in HDFN or FNAIT-Affected Pregnancies: Results of a Landscape Assessment and Clinician and Patient Interviews

    Jun 1, 2024, 00:00

  • HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results

    Jun 1, 2024, 00:00

  • EE52 The Burden of Intravenous vs Subcutaneous Oncological Products Application in Honduras

    Jun 1, 2024, 00:00

  • HPR121 Impacts of National Drug Price Negotiation on Chronic Myeloid Leukemia Drugs Price, Volume and Spending in China

    Jun 1, 2024, 00:00

  • HSD54 Assessing the Impact of Telehealth Delivery on Adherence to Medications for Opioid Use Disorder

    Jun 1, 2024, 00:00

  • PCR166 Real-World Discontinuation of High-Efficacy Disease Modifying Therapies for the Treatment of Multiple Sclerosis: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE447 Evaluating the Impact of Disease Prevalence and Product Administration on Launch Pricing Trends for Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • RWD57 Trends and Factors Affecting the Initiation of Denosumab and Zoledronic Acid Among Metastatic Lung, Breast, and Prostate Cancer Patients in the United States

    Jun 1, 2024, 00:00

  • HPR70 Racial Disparity and Utilization of Disease-Risk Genetic Testing: A Nationwide Sampling Survey Analysis

    Jun 1, 2024, 00:00

  • MT6 Clinical Significance of SP-D Biomarker in the Diagnosis of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • CO72 Investigating Regional Differences in Cardiovascular Outcomes Among Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • HPR37 Racial Disparities in Homologous Recombination Repair (HRR) Biomarker Testing in the United States: A Real-World Database Analysis Among White and Non-White Patients with Metastatic Prostate Cancer

    Jun 1, 2024, 00:00

  • CO60 A Vocation for Life on Land, Sea and Air - Health Assessment of Ambulance Workers

    Jun 1, 2024, 00:00

  • PCR35 Impact of COVID-19 Vaccination with BNT162b2 on the Frequency of Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

    Jun 1, 2024, 00:00

  • MSR93 Patient Cloning for Assessing Dynamic Treatment Protocols: A Novel Approach for Observational Data Analysis Using Real-World Data (RWD)

    Jun 1, 2024, 00:00

  • CO18 Impact of Empiric Treatment Failure on Healthcare Resource Utilization and Costs Among Females With Uncomplicated Urinary Tract Infections in a US-Based Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • HTA20 Population Adjusted-Indirect Comparisons in Health Technology Assessment: A Methodological Systematic Review

    Jun 1, 2024, 00:00

  • MSR88 The Influence of Social Determinants of Health on Healthcare Access, Utilization, and Treatments in Atopic Dermatitis Patients Using All of Us and Machine Learning Methods

    Jun 1, 2024, 00:00

  • MSR16 Examining Fairness in Machine Learning Predictions of Healthcare Costs in Older Women With Osteoarthritis: XGBoost Regression

    Jun 1, 2024, 00:00

  • EE92 Trends in Incidence and Economic Burden of Pneumonia in the United States from 2016-2021

    Jun 1, 2024, 00:00

  • CO178 Access to Preventive Care and Social Determinants of Child Obesity: A Retrospective Cohort Study Using the Pinc AI™ Healthcare Database (PHD)

    Jun 1, 2024, 00:00

  • RWD25 Trends and Utilization of Open, Laparoscopic, and Robotic-Assisted Appendectomy: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • OP15 Correlation between Quality of Care and Financial Risk Indicators in Public Hospitals

    Jun 1, 2024, 00:00

  • EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Treatment and Response to Therapy in Canadian Patients

    Jun 1, 2024, 00:00

  • PCR182 A Triangulation Approach to Develop a Conceptual Framework for the Patient-Reported Outcome Measures across the Life Cycle: A Case of Patients with X-Linked Hypophosphatemia

    Jun 1, 2024, 00:00

  • HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence

    Jun 1, 2024, 00:00

  • CO25 Examining the Effectiveness of Rotator Cuff Training on Shoulder Joint Stability, Mobility and Shooting Accuracy Among Basketball Players

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • RWD178 Costs of Cancer Care Across the Disease Continuum: An Analysis From a Health Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • CO1 The Rate of Ward to Intensive Care Transfer and Its Predictors Among Hospitalized COPD Patients: A Retrospective Study in a Local Tertiary Center in Saudi Arabia

    Jun 1, 2024, 00:00

  • HPR101 Impacts of the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain on Opioid Prescribing and Pain Management Outcomes: A Systematic Review

    Jun 1, 2024, 00:00

  • EE383 Cost-Utility Analysis of Adapted Problem Adaptation Therapy for Depression in Mild to Moderate Dementia Caused by Alzheimer's Disease: Pathfinder Randomized Controlled Trial

    Jun 1, 2024, 00:00

  • RWD40 Concomitant Use of Opioids and Psychotropic Medications in Mississippi Medicaid Beneficiaries

    Jun 1, 2024, 00:00

  • RWD56 Expert Consensus on Diagnosis, Risk Stratification, and Treatment of Smoldering Multiple Myeloma: Results From a Multinational Delphi Panel Study

    Jun 1, 2024, 00:00

  • PCR14 Development and Validation of Two New Patient-Reported Outcome Measures for Recurrent Urinary Tract Infection: The Recurrent UTI Symptom Scale (RUTISS) and the Recurrent UTI Impact Questionnaire (RUTIIQ)

    Jun 1, 2024, 00:00

  • EPH199 Social Determinants of Health Associated with Delayed Medical Care in an Online Health Community

    Jun 1, 2024, 00:00

  • EE278 Cost-Effectiveness Analysis of Premature Infant Oral Motor Intervention (PIOMI) in the Neonatal Intensive Care Unit in Colombia, 2022

    Jun 1, 2024, 00:00

  • P10 Using the Health Improvement Distribution Index to Inform Equitable Machine Learning: An Example Analysis Among Patients with Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • PCR265 Measurement of Health Insurance Literacy and Identification of Its Correlates Among Working-Age Cancer Survivors in the US

    Jun 1, 2024, 00:00

  • MT38 Electromagnetic Navigation Bronchoscopy (ENB) Versus Shape-Sensing Robotic-Assisted Bronchoscopy (ssRAB) Lung Navigation Platforms: A Cost-Minimization Analysis

    Jun 1, 2024, 00:00

  • P48 Automating Economic Modelling: Potential of Generative AI for Updating Excel-Based Cost-Effectiveness Models

    Jun 1, 2024, 00:00

  • CO163 Impact of Glucocorticoid Use on Mortality in Adults with Chronic Diseases: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HPR108 The Patient Access Landscape for Rare Disease Medicines in Brazil: A Multi-Stakeholder Perspective

    Jun 1, 2024, 00:00

  • CO87 The Patient Journey of Bariatric Surgery – a Study Comparing the Healthcare and Medication Utilization before and after the Bariatric Surgery

    Jun 1, 2024, 00:00

  • HSD55 Real-World Medication Management of Adults With Sickle Cell Disease in the United States

    Jun 1, 2024, 00:00

  • MSR86 Leveraging Large Language Models for Efficient Observational Research Protocol Drafting: Insights and Best Practices for Openllama

    Jun 1, 2024, 00:00

  • Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Jun 1, 2024, 00:00

  • MT10 Higher SARS-CoV-2 Spike Antibody Levels Are Associated With Reduced Risk of Subsequent Symptomatic and Severe COVID-19: A Real-World Data Study

    Jun 1, 2024, 00:00

  • P2 Economic Burden and Healthcare Resource Utilization in Sjögren's Disease: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • CO27 Survival and Cost of Care By Type of First-Line Therapy in Metastatic Non-Small Lung Cancer Using SEER-Medicare Data

    Jun 1, 2024, 00:00

  • EPH6 Changes in the Midwives Density per 1,000 Live Births in Europe

    Jun 1, 2024, 00:00

  • RWD34 Examining Bias in the Narxcare Score: Unveiling Disparities in AI/ML Features for Opioid Prescribing Decisions

    Jun 1, 2024, 00:00

  • SA77 Race and Ethnicity in Oracle EHR Real-World Data: A Contrast to Self-Reported Data in the United States

    Jun 1, 2024, 00:00

  • P23 Validity of the EQ-HWB-S in United States-Based Caregivers

    Jun 1, 2024, 00:00

  • EE429 Optimizing Multicancer Early Detection (MCED) Testing Based on Patient Stratification: A Comprehensive Analysis of Economic and Clinical Impact from a US Payer Perspective

    Jun 1, 2024, 00:00

  • PCR105 Does Availability of Rare Disease Treatment Improve Time to Diagnosis?

    Jun 1, 2024, 00:00

  • EE502 Healthcare Resource Utilization and Cost Burden in Patients with Primary Biliary Cholangitis

    Jun 1, 2024, 00:00

  • EE310 The Burden of Blood Transfusions Associated With Lower-Risk Myelodysplastic Syndromes (LR-MDS): Findings From a Survey of Health Care Professionals (HCPs) in Brazil, Germany, and Japan

    Jun 1, 2024, 00:00

  • SA44 Association between Facilities of First COVID-19 Diagnosis and Previous Outpatient Visits Based on a Claims Database Analysis

    Jun 1, 2024, 00:00

  • PCR236 Analyzing Possible Diagnostic Delay Factors in Gynaecological and Andrological Diseases Among Secondary School Students

    Jun 1, 2024, 00:00

  • HSD83 Multimorbidity Patterns and Related Treatment Costs Among Middle-Aged and Older Diabetes Patients in China

    Jun 1, 2024, 00:00

  • HPR15 Comparison of Price Index Methods and Drug Price Inflation Estimates for Medications for Opioid Use Disorder (MOUD)

    Jun 1, 2024, 00:00

  • CO152 Glycemic Control and Long-Term Macrovascular Outcomes in People With Type 2 Diabetes in China: A Retrospective Study

    Jun 1, 2024, 00:00

  • SA4 Missingness Patterns in a Survey of Barriers to Care Among Individuals Diagnosed With Cancer: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • PCR268 Association Between Screen Time, Social Support, and Mental Health in Adolescents: Evidence From a Nationally Representative Sample in 2022

    Jun 1, 2024, 00:00

  • HSD25 Patients’ Rare Disease Diagnoses and Their Impact on Physicians’ Emotions: A Cross-Sectional Study in the United States

    Jun 1, 2024, 00:00

  • HPR1 Prescription Nutraceutical Clinical Evidence Requirements in the Treatment of Depression: Comparing US and EU Guidance for Phase II and III Clinical Trials

    Jun 1, 2024, 00:00

  • HTA4 Criteria for Decision Making in Health Economic Evaluations: An Analysis of Global Practices

    Jun 1, 2024, 00:00

  • MT2 Operating Room (OR) and Sterilization Efficiencies for Total (TKA), Revision (rTKA) and Unicompartimental Knee Arthroplasty (UKA) Using a Handheld Robotic Assisted (RA) Surgical System

    Jun 1, 2024, 00:00

  • EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States

    Jun 1, 2024, 00:00

  • RWD59 Determinants of Smoking Cessation Program Completion and Continued Tobacco Use in a Referral Program: An EHR Data Analyses From 2018-2023

    Jun 1, 2024, 00:00

  • PCR190 Food Insecurity As a Determinant of Poorer Health-Related Quality of Life Among Patients with Chronic Conditions in the United States

    Jun 1, 2024, 00:00

  • RWD9 Anhedonia-Related Wording in Social Media: An Application of Natural Language Processing

    Jun 1, 2024, 00:00

  • HSD37 Prescribing Trends of Newly Approved Sickle Cell Disease-Modifying Medications

    Jun 1, 2024, 00:00

  • MSR43 Identifying Eligibility for Chimeric Antigen Receptor T-Cell Therapy Among Diffuse Large B-Cell Lymphoma Patients Using Real-World Data and Unsupervised Machine Learning

    Jun 1, 2024, 00:00

  • CO166 Patient Reported Outcomes of Vonoprazan in Chinese Reflux Esophagitis Patients: A Prospective Real-World Study

    Jun 1, 2024, 00:00

  • PCR180 Measuring and Valuing Child Health in Canada

    Jun 1, 2024, 00:00

  • RWD94 Targeting a Modifiable Risk Factor: A Causal Framework Informs Strategies to Reduce Pressure Injuries

    Jun 1, 2024, 00:00

  • EE111 Optimization of the Health Economic Model of Type 2 Diabetes Based on Glycemic Variability Mechanism

    Jun 1, 2024, 00:00

  • MSR37 Methodological Review on Delphi Technique: Expert Definition and Retention in Rare Diseases

    Jun 1, 2024, 00:00

  • HSD4 First-Generation Antipsychotic Shortages in the United States: Analysis of Switching and Utilization Patterns

    Jun 1, 2024, 00:00

  • RWD83 Real-World Treatment Patterns in Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States

    Jun 1, 2024, 00:00

  • P8 Projections of Costs and Prevalence of Opioid Drug Prescriptions in the U.S. from 2025 - 2050

    Jun 1, 2024, 00:00

  • EPH95 Leveraging Data Aggregators to Annotate Deidentified Genomic Data Derived from Commercial Laboratory Specimens to Study COVID-19 Severity

    Jun 1, 2024, 00:00

  • PCR29 Patient and Caregiver Perspectives Regarding Once-Weekly Injection Devices in Growth Hormone Deficiency: Qualitative Interviews To Inform a Patient Preference Study

    Jun 1, 2024, 00:00

  • EE54 A Framework for Evaluating the Economic Impact of Artificial Intelligence for Screening Mammography: Implications for Facilities and Payers from the US Perspective

    Jun 1, 2024, 00:00

  • HPR53 How Does the Inclusion of New Drugs in National Reimbursement Drug List Influence Health Outcomes and Financial Burden for Multiple Sclerosis Patients

    Jun 1, 2024, 00:00

  • PT24 Quality Appraisal of Randomized Controlled Trials Using Robins 2.0 Tool: A Case Study on Comparing the Performance of ChatGPTv4.0 With a Human Reviewer

    Jun 1, 2024, 00:00

  • EE27 Cost-Effectiveness of Chondroitin Sulfate Plus Glucosamine Versus Celecoxib for Moderate To Severe Knee Osteoarthritis

    Jun 1, 2024, 00:00

  • EE102 Estimate Broader Economic Impact of Lecanemab for Medicare Beneficiaries Alzheimer's Disease Patients: Budget Impact and Input-Output Models

    Jun 1, 2024, 00:00

  • CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature

    Jun 1, 2024, 00:00

  • EE338 NICE Reconsideration for Oncology Drugs Based on Single-Arm Trials Referred to Cancer Drug Fund

    Jun 1, 2024, 00:00

  • EE13 Cost-Effectiveness Analysis of Duodenal–Jejunal Bypass Sleeve Device for People With Obesity

    Jun 1, 2024, 00:00

  • P62 Targeted Literature Review of the Use of Real-World Evidence From Single Real-World Data Sources and in Meta-Analyses: Methodologies and Recommendations From Health Technology Assessment Bodies

    Jun 1, 2024, 00:00

  • EE409 An Applicable Method to Estimate the Broader Value of Antibiotics: Dynamic Transmission Model

    Jun 1, 2024, 00:00

  • EPH93 Trends and Regional Variation in New Opioid Prescriptions and Long-Term Prescription Opioid Use Among Older Adults in the United States, 2012-2020

    Jun 1, 2024, 00:00

  • MT20 Validation of the Sensal Health Smart Dock TM Medication Adherence Device

    Jun 1, 2024, 00:00

  • MT19 A High-Quality, Low-Cost Patient Care Model: Barcode-Based Counseling

    Jun 1, 2024, 00:00

  • RWD131 Replicating Published Real-World Evidence Studies Using Electronic Medical Records From Community Hospitals

    Jun 1, 2024, 00:00

  • EE73 Direct Healthcare Costs Associated With Primary Symptomatic Cytomegalovirus in the United States

    Jun 1, 2024, 00:00

  • HPR11 Revenue-Sharing or Revenue Lost? The Hidden Costs of 340B to Employers

    Jun 1, 2024, 00:00

  • EE74 Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • PCR42 Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Longitudinal Study Using the EQ5D and Health Utilities Index (HUI)

    Jun 1, 2024, 00:00

  • EPH12 A Retrospective Natural History Study of Incident Adult Dermatomyositis and Polymyositis Patients Using Real World Data

    Jun 1, 2024, 00:00

  • HSD125 Second-Line Antidiabetic Agent Order Patterns in Patients With Type 2 Diabetes Across Healthplan Types

    Jun 1, 2024, 00:00

  • SA12 Investigator Choice Comparator Arms in Oncology Clinical Trials: Implications for HTA/Reimbursement Assessments

    Jun 1, 2024, 00:00

  • EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?

    Jun 1, 2024, 00:00

  • EE314 Costs of Transcatheter Versus Surgical Aortic Valve Replacement in Brazil

    Jun 1, 2024, 00:00

  • EE321 Budget Impact Model for Dasiglucagon in the Prevention and Treatment of Hypoglycemia in Pediatric Patients with Congenital Hyperinsulinism in the United States

    Jun 1, 2024, 00:00

  • EE486 Impact of COVID-19 Pandemic on IV Iron (IVI) Cost and Utilization in Commercially-Insured Patients With Iron Deficiency Anemia (IDA)

    Jun 1, 2024, 00:00

  • HTA36 ATMP Reimbursement: A Targeted Review of Global HTA Assessment Trends

    Jun 1, 2024, 00:00

  • MSR10 Cardiovascular Events Prediction on a Synthetic Cohort in Low-Income Setting with Machine Learning

    Jun 1, 2024, 00:00

  • EE242 Economic and Clinical Impact of Cost-Effective Kidney-Related Healthcare Interventions to Manage the Burden of CKD in the UK: Estimates for the Next 10 Years (2023 to 2033)

    Jun 1, 2024, 00:00

  • CO44 Exploring the Impact of Non-Steroidal Immunosuppressive Drugs and Steroids on the Development of Comorbidities in Patients With Myasthenia Gravis in the National Veterans Affairs Health Network

    Jun 1, 2024, 00:00

  • EE134 Budget Impact Analysis of Machine Learning Models for Diagnosing Alzheimer's Dementia

    Jun 1, 2024, 00:00

  • OP17 Are Dengue-Related Technological Solutions Evolving to Address the Global Public Health Problem?

    Jun 1, 2024, 00:00

  • EE438 A Budget Impact Model (BIM) for the Introduction of the TEARCARE® System to a United States (US) Health Plan for the Treatment of Meibomian Gland Dysfunction (MGD)-Associated Dry Eye Disease (DED)

    Jun 1, 2024, 00:00

  • EPH17 Prevalence and Characteristics of Urinary Tract Infections in Office-Based Physician Practices in the United States, 2016–2019

    Jun 1, 2024, 00:00

  • HPR106 Pricing of New Oncology Products in the US and Key European Markets

    Jun 1, 2024, 00:00

  • HPR116 Do US Managed Care Organizations Restrict Coverage More Than the Food and Drug Administration Label?

    Jun 1, 2024, 00:00

  • PCR145 Using Survey Data and Qualitative Interviews to Support Content Validity for Spinocerebellar Ataxia (SCA) Patients

    Jun 1, 2024, 00:00

  • HTA70 Early Patient Access to Life Saving Drugs across Europe – A Review of the Characteristics and Availability of Drugs in Early Access Programs in EU4 and the UK

    Jun 1, 2024, 00:00

  • RWD185 Prediction of Disease Severity Using Machine Learning Algorithms: An Analysis for Chronic Kidney Disease in the US

    Jun 1, 2024, 00:00

  • MSR80 Estimands and Strategies for Handling Treatment Switching As an Intercurrent Event in Evidence Synthesis of Randomized Clinical Trials in Oncology

    Jun 1, 2024, 00:00

  • PCR26 Impact of Attention-Deficit/Hyperactivity Disorder Treatment Adverse Effects on Quality of Life and Functioning of Pediatric Patients and Their Parents/Caregivers

    Jun 1, 2024, 00:00

  • CO175 Quality of Life and Productivity Loss Cost Associated with Low Back Pain By Severity in Korea

    Jun 1, 2024, 00:00

  • PCR220 Enhancing Non-Experts' Understanding of Uncertainty in Psychometric Results through Effective Visual Probabilistic Representations

    Jun 1, 2024, 00:00

  • EPH105 Obesity Continues to be Associated With Poor Health-Related Quality of Life During the Third Year of the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study

    Jun 1, 2024, 00:00

  • EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database

    Jun 1, 2024, 00:00

  • CO56 Evaluation of Real-World Treatment Outcomes Among Women 50 Years of Age and Older Who Were Treated With Statin + Ezetimibe or Statin Monotherapy in Italy and Belgium

    Jun 1, 2024, 00:00

  • EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model

    Jun 1, 2024, 00:00

  • PCR208 The Association of Intentional Weight Reduction with Symptom Burden and PRO Measures in Patients with Obstructive Sleep Apnea: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HPR103 Calcimimetic Prescriptions Following the Transitional Drug Add-on Payment Adjustment in Fee-for-Service Medicare Patients on Dialysis

    Jun 1, 2024, 00:00

  • PCR237 Assessing the Presence of Anxiety and Depression Among Pregnant Women

    Jun 1, 2024, 00:00

  • EE176 Economic Burden and Healthcare Resource Utilization in Patients with Psoriatic Arthritis (PsA): A Systematic Literature Review

    Jun 1, 2024, 00:00

  • RWD120 Evaluating the Impact of Human Growth Hormone (HGH) Drug Shortages on Patient Treatment Switching Patterns Using Real-World Data

    Jun 1, 2024, 00:00

  • CO102 The Importance of Potassium Ion Disturbances in Emergency Care

    Jun 1, 2024, 00:00

  • HPR68 How Will the New VPAG Rebate Regulations Affect Launch Strategy in the UK?

    Jun 1, 2024, 00:00

  • RWD29 Predictive Model for Dementia in Patients with Type 2 Diabetes Using a Common Data Model

    Jun 1, 2024, 00:00

  • HTA26 Economic Evaluation Submitted for Reimbursement in the Brazilian Unified Health System: A Meta-Epidemiological Study

    Jun 1, 2024, 00:00

  • EPH215 Recent Trends in the Incidence and Prevalence of Atopic Dermatitis in the United States: Eliciting Differences by Age and Sex

    Jun 1, 2024, 00:00

  • PCR12 Exploring Patterns of Treatment Utilization and Promis Scores in a Home-Reported Outcomes Study for Individuals with Sickle Cell Disease (SCD)

    Jun 1, 2024, 00:00

  • P51 Characterization of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • EE356 Economic Burden of Diseases Caused By Overweight and Obesity in Mexico

    Jun 1, 2024, 00:00

  • EE97 Micro-Costing of Relapse and Refractory EGPA Treatment in Brazil Using the Lens of Experts

    Jun 1, 2024, 00:00

  • PCR9 Role of Video Versus Text Information in Willingness to be Vaccinated for Invasive Meningococcal Disease Among US Adolescents/Young Adults and Parents

    Jun 1, 2024, 00:00

  • Perspectives on Improving Value Assessment With the ISPOR SUITABILITY Checklist [Editor's Choice]

    Jun 1, 2024, 00:00

  • CO94 Advancing Diabetes Care: Novel Drug Interventions in the Management and Control of Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • EE145 The Economic Impact of Overweight and Obesity-Related Diseases in Colombia

    Jun 1, 2024, 00:00

  • PCR112 Exploring Rare Disease Landscape Using Social Media Listening to Assess Patient Voices

    Jun 1, 2024, 00:00

  • PCR174 Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review

    Jun 1, 2024, 00:00

  • CO62 Clinical Outcomes of Second-Line (2L) Treatments (TXS) in Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE137 Economic Burden for Adults With Sickle Cell Disease and Matched Controls in the United States: Retrospective Analysis of a Commercial Insurance Database

    Jun 1, 2024, 00:00

  • CO43 A Systematic Literature Review of Comparative Efficacy Measures in Randomized Controlled Trials of Darolutamide Treatment in Metastatic Hormone-Sensitive Prostate Cancer

    Jun 1, 2024, 00:00

  • HSD117 Causes and Characteristics of Drug Shortages in the United States

    Jun 1, 2024, 00:00

  • EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada

    Jun 1, 2024, 00:00

  • RWD128 Herpes Zoster Infection in Adults With Rheumatic Diseases in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HPR78 Eliciting Inequality Aversion in the United States: Results from a Benefit Trade-Off Experiment

    Jun 1, 2024, 00:00

  • PCR43 Health Utility Decrement of Injection Treatment-Related Attributes Among Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • EE303 Economic Costs of Informal Care for Individuals with Disabilities and Chronic Diseases in Hong Kong

    Jun 1, 2024, 00:00

  • P63 Comparative Analysis of Health Technology Assessment Agency Frameworks for Digital Health Technologies

    Jun 1, 2024, 00:00

  • EE103 Cost-Effectiveness of Universal Newborn Screening for Spinal Muscular Atrophy With Disease-Modifying Therapies in Taiwan

    Jun 1, 2024, 00:00

  • EPH227 Identifying Prediabetes Patients Using Administrative Claims Linked with Lab Data to Assess Progression to Type 2 Diabetes

    Jun 1, 2024, 00:00

  • EE249 Healthcare Utilization and Costs Associated with Remote Blood Pressure Monitoring in a US Integrated Healthcare System

    Jun 1, 2024, 00:00

  • SA25 Diagnostic Test Accuracy of Serum Amylase and Lipase for Diagnosing Acute Pancreatitis: A Meta-Analysis

    Jun 1, 2024, 00:00

  • EPH65 Burden of Illness of Osteogenesis Imperfecta in Ontario, Canada

    Jun 1, 2024, 00:00

  • CO134 Association between Baseline Lung Function and Oral Corticosteroid Elimination in Patients with Oral Corticosteroid-Dependent Severe Asthma

    Jun 1, 2024, 00:00

  • EE378 Economic Burden of Non-Hodgkin Lymphoma Among Patients with Commercial Insurance

    Jun 1, 2024, 00:00

  • EE83 Total Costs and Cost Savings of Comprehensive Knee Osteoarthritis Management Combined With Total Knee Arthroplasty in an Ambulatory Surgical Center

    Jun 1, 2024, 00:00

  • P35 Are Proposals for a Scheme to Stimulate Investment in Critically Needed New Antimicrobials Fit for Purpose?

    Jun 1, 2024, 00:00

  • RWD62 Enriching the Value of Real-World Oncology Data With Important Clinical Information From Unstructured Data Sources for Better Clinical Insight Generation

    Jun 1, 2024, 00:00

  • HSD21 Relationships Between Census Tract-Level Social Determinants of Health and Cardiovascular Care Among Individuals Diagnosed With Breast Cancer

    Jun 1, 2024, 00:00

  • CO103 Antidepressant Adherence Using Group-Based Trajectory Modeling Among Postpartum Women With Texas Medicaid

    Jun 1, 2024, 00:00

  • HPR52 Disparity in New Cancer Drug Launches Worldwide: 1990-2022

    Jun 1, 2024, 00:00

  • P11 Beyond Accuracy: Fairness Implications in High-Cost User Prediction Models Among Incident Lung Cancer Survivors

    Jun 1, 2024, 00:00

  • EPH139 Adverse Events Associated with Enzyme Replacement Therapies Lysosomal Glycogen-Specific Enzyme (GAA) Medications for the Treatment of Pompe Disease

    Jun 1, 2024, 00:00

  • PCR257 Beliefs and Factors Associated With Intentions to Initiate Antihypertensive Medications

    Jun 1, 2024, 00:00

  • PCR18 Systematic Literature Review of Health Utility Values in Adult Patients with Post-Traumatic Stress Disorder

    Jun 1, 2024, 00:00

  • HPR92 Assessment of Surrogate Endpoints in Real-World Oncology Studies, a Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE42 Value of Being the First Biosimilar Entrant

    Jun 1, 2024, 00:00

  • EE1 Comparative Cost-Effectiveness Analysis of Interventions for Perinatal Methamphetamine Use Disorder: A Decision Modeling Method

    Jun 1, 2024, 00:00

  • PCR150 Burden of Invasive Meningococcal Disease in Survivors and Their Caregivers in the United States: A Cross-Sectional Non-Interventional Mixed Methods Study

    Jun 1, 2024, 00:00

  • HTA21 Organizations Responsible for the Evaluation of Health Technologies Globally: A Scoping Review

    Jun 1, 2024, 00:00

  • EE23 Evaluation of the Relative Impact of Factors Influencing Originator U.S. Market Share Following Biosimilar Launch

    Jun 1, 2024, 00:00

  • RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022

    Jun 1, 2024, 00:00

  • SA21 Economic Analysis of Germline Genetic Testing to Assess for Hereditary Colorectal Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • RWD75 Machine Learning in Healthcare: Analyzing Cost Prediction Biases to Ensure Health Equity Among Older Adults With Incident Hodgkin’s Lymphoma

    Jun 1, 2024, 00:00

  • HPR59 Do All US Payer Archetypes Consider the Same Sources of Evidence to Inform Their Drug Policies?

    Jun 1, 2024, 00:00

  • EPH79 HPV-Associated Cancers in Men: Epidemiological and Economic Burden in Costa Rica

    Jun 1, 2024, 00:00

  • RWD173 Using Population Data to Develop Precision Based Approaches to Hepatits C Prevention

    Jun 1, 2024, 00:00

  • EE523 Costs Per Responder With Venetoclax in Combination With Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • EE389 Economic Burden of Diagnosed Congenital Cytomegalovirus in the United States and Japan

    Jun 1, 2024, 00:00

  • EE95 Value Comparison of BACT/ALERT®; VIRTUO® System Versus BD BACTEC™ FX Blood Culture System from a Provider Perspective

    Jun 1, 2024, 00:00

  • HTA74 Better Late Than Never? Payer Appetite and Vision for a National Value Assessment Body

    Jun 1, 2024, 00:00

  • EE481 Long-Term Cost-Effectiveness of Tirzepatide Versus Placebo for Individuals With Type 2 Diabetes and Obesity

    Jun 1, 2024, 00:00

  • RWD64 Comorbidities of Irritable Bowel Syndrome in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE380 Exploring the Impact of a Rare Disease (RD) Diagnosis on Work Productivity and Social Activity Impairment: A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • EE381 Comparative Analysis of Patient Outcomes and Hospital Costs: Robotic-Assisted Surgery Versus Conventional Laparoscopic Surgery Across Five Procedures

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • HTA45 Comparison of the Use of Real-World Evidence for Clinical Effectiveness in HTA Pre- and Post- Introduction of the NICE Framework – an Update

    Jun 1, 2024, 00:00

  • MSR49 Long-Term Survival Prediction in Early Breast Cancer: A Machine Learning Approach With Random Survival Forest

    Jun 1, 2024, 00:00

  • HSD102 Job Preferences of Caregivers in Integrated Medical and Nursing Care Facilities: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • PCR259 No Value Without Equity: Transforming Power, People and Process for Equity in Health Technology Assessment

    Jun 1, 2024, 00:00

  • PCR8 Comparison of the Sociodemographic Characteristics and Various Indicators of Patients with Acute Ischemic Stroke

    Jun 1, 2024, 00:00

  • PCR73 Health Care for People with Autism in the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • RWD27 Creation of a Data Quality Framework for a United States Electronic Medical Record-Based Registry for Individuals with Spinal Muscular Atrophy

    Jun 1, 2024, 00:00

  • EPH223 Excess of Mortality By Asthma during COVID-19 Pandemic in Colombia

    Jun 1, 2024, 00:00

  • RWD159 Assessing the Relationship between Initial Opioid Prescription and Subsequent Pain-Related Healthcare Resource Utilization and Costs Among Patients with Chronic Pain

    Jun 1, 2024, 00:00

  • MT12 Economic Outcomes of Polarstem Stem, R3 Acetabular Shell and Oxidized Zirconium Femoral Heads (POLAR3) Vs Non-POLAR3 Implant System in Total Hip Arthroplasty: A Real World Evidence Analysis

    Jun 1, 2024, 00:00

  • EPH103 Fatal Outcomes from Drug Interactions: Insights from the FDA Adverse Event Reporting System

    Jun 1, 2024, 00:00

  • EE146 Comparative Analysis of the Burden of Illness Among Juvenile Idiopathic Inflammatory Myopathy Versus Juvenile Idiopathic Arthritis in the United States

    Jun 1, 2024, 00:00

  • CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)

    Jun 1, 2024, 00:00

  • HTA48 Systematic Review and Quality Assessment of Clinical and Economic Evidence For Superabsorbent Wound Dressings in a Population with Chronic Ulcers

    Jun 1, 2024, 00:00

  • PCR251 A Conceptual Disease Model for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer (aGC/GEJC): Results From a Targeted Literature Review and Patient Interviews

    Jun 1, 2024, 00:00

  • EE421 Integrating Payer Reimbursement Strategies Into Modeling and Simulation (MS)-Based Methods to Redefine Drug Development

    Jun 1, 2024, 00:00

  • CO192 A Retrospective Database Analysis of US Medicaid Treatment-Naive People With HIV (PWH) With or Without Mental Health Disorders (MHDs) Initiating Single-Tablet Regimens (STRs) Vs. Multi-Tablet Regimens (MTRs)

    Jun 1, 2024, 00:00

  • PCR88 Overall Retention and Characteristics Associated With Longitudinal Completion of Remote Patient-Reported Outcome Questionnaires in a Representative, General Population Cohort Study: The Project Baseline Health Study

    Jun 1, 2024, 00:00

  • HSD78 Prescribing Patterns of Novel Oral Therapies for Ulcerative Colitis in a Large Integrated Delivery Network

    Jun 1, 2024, 00:00

  • RWD45 Inequalities in the Costs and Affordability of a Healthy Diet in Europe between 2017 and 2021

    Jun 1, 2024, 00:00

  • MT24 The State of Single-Use Ureteroscopy in the United States

    Jun 1, 2024, 00:00

  • EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol

    Jun 1, 2024, 00:00

  • EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years

    Jun 1, 2024, 00:00

  • MSR79 Evaluation of Real-World Response Rate in Clinical Trial-Aligned Cohorts of Patients With Lung, Colon, and Breast Cancer Using Machine Learning

    Jun 1, 2024, 00:00

  • PT1 Incorporating Stakeholder Perspectives Into Open-Source Model Building for Major Depressive Disorder

    Jun 1, 2024, 00:00

  • EPH83 Mortality Rate By Tuberculosis in Colombia, 2012-2021: Regional Inequalities

    Jun 1, 2024, 00:00

  • PCR143 Diagnostic Delay of Multiple Sclerosis in China: A Nationwide Cross-Sectional Study

    Jun 1, 2024, 00:00

  • MSR85 Efficacy of Modern Oral Antidiabetic Drugs: A Systematic Literature Review Network Meta-Analysis

    Jun 1, 2024, 00:00

  • Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • HSD5 Real-World Treatment Patterns in Adults with Pemphigus Foliaceus in the United States

    Jun 1, 2024, 00:00

  • EPH48 Would Exposure to Metformin Reduce Mortality in Patients With Glioblastioma?

    Jun 1, 2024, 00:00

  • EE178 Evaluating the Budget Impact of Introducing Preventive Therapy in the Preclinical Phase for Rheumatoid Arthritis : A Focus on Algerian Female Population at Risk

    Jun 1, 2024, 00:00

  • PCR114 Young People’s Barriers and Facilitators of Engagement With Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study

    Jun 1, 2024, 00:00

  • EPH104 Public Health Impact of Pediatric BNT162b2 XBB1.5-Adapted COVID-19 Vaccine in the United States

    Jun 1, 2024, 00:00

  • PCR155 Health-Related Quality of Life Among High School Students with Myopia in China

    Jun 1, 2024, 00:00

  • PCR37 Differences in PHQ-9 Scores Based on Remote Digital Versus in-Person Administration: Findings From the Project Baseline Health Study

    Jun 1, 2024, 00:00

  • PCR262 The Use of Artificial Intelligence Chat To Improve Readability of Patient-Facing Materials

    Jun 1, 2024, 00:00

  • PCR113 Patients’ Perspectives on Bleeding, Bruising, and Other Key Changes Associated With Antithrombotic Treatment

    Jun 1, 2024, 00:00

  • EE291 Schizophrenia and Bipolar Disorder Burden and Economic Burden Under an Impact Analysis by Therapeutic Scheme

    Jun 1, 2024, 00:00

  • HPR152 The Impact of Insurance Reform on Health Resource Utilization and Persistence for Chinese Patients With Crohn’s Disease, Taking Ustekinumab as an Example: Evidence From a Natural Experiment Study

    Jun 1, 2024, 00:00

  • HPR112 Variation in Coverage of Specialty Therapies and Barriers to Fair Access

    Jun 1, 2024, 00:00

  • PCR22 Assessing the Implementation of the "Baby-Friendly Hospital Initiative” in Hungary

    Jun 1, 2024, 00:00

  • RWD127 Combining Patients’ Perspectives and Treatment/ Healthcare Resource Utilization in Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

    Jun 1, 2024, 00:00

  • CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening

    Jun 1, 2024, 00:00

  • EPH198 Analyzing the Impact of Colorectal Cancer Diagnosis on Treatment Adherence Amongst Patients With Preexisting Hypertension

    Jun 1, 2024, 00:00

  • MSR70 Acceptance of Artificial Intelligence Augmented Systematic Reviews by Health Technology Assessment Bodies

    Jun 1, 2024, 00:00

  • PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial

    Jun 1, 2024, 00:00

  • HSD32 Treatment Patterns and Healthcare Resource Use Among Patients With Axial Spondyloarthritis and Comorbid Inflammatory Bowel Disease

    Jun 1, 2024, 00:00

  • The Relative Importance and Performance of Key Life Domains on Global Life Satisfaction in Early Adolescents

    Jun 1, 2024, 00:00

  • RWD65 Characteristics of Real-World Databases in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • MT22 Mapping Definitions of Patient-Facing Digital Health Intervention in Published Frameworks Against the PICOTS-ComTeC Minimum Information Framework

    Jun 1, 2024, 00:00

  • HPR14 Lessons From History: Gauging Part D Plan Access Restrictions of Protected Class Drugs as a Harbinger for Coverage of Negotiated Drugs

    Jun 1, 2024, 00:00

  • HTA39 Long-Term Health-Related Quality of Life in Esophageal Cancer Survivors: A Literature Review

    Jun 1, 2024, 00:00

  • P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

    Jun 1, 2024, 00:00

  • MT41 Outcomes and Costs Associated With Cervical Spinal Fusion Surgery

    Jun 1, 2024, 00:00

  • Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses [Editor's Choice]

    Jun 1, 2024, 00:00

  • RWD108 Demographics, Clinical Characteristics, and Treatment Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the US Across Social Determinants of Health (SDoH)

    Jun 1, 2024, 00:00

  • EE239 Predictive Cost-Effectiveness Evaluation of Using a Machine Learning-Based Alzheimer’s Disease Risk Prediction Tool for Users of Social and Health Services Aged over 65 in Finland

    Jun 1, 2024, 00:00

  • EE246 Consideration of the Cost of Adverse Events for Oncology Treatment: A Review of Cost-Effectiveness Evaluations in Japan

    Jun 1, 2024, 00:00

  • EE159 Price, Spending, and Utilization of Second-Generation Antipsychotics and the Impact of Generic Entry on Market Shares: Trend Analysis of Medicaid Database From 1991 to 2022

    Jun 1, 2024, 00:00

  • RWD112 Going Beyond Claims: Unleashing the Power of Diverse Healthcare Datasets in Clinical and HEOR Assessments

    Jun 1, 2024, 00:00

  • PCR16 Clinical Actions Generated By Remote Symptom Alerts and Electronic Patient-Reported Outcomes (ePROs) in Real-World Breast Cancer Practice

    Jun 1, 2024, 00:00

  • RWD181 Healthcare Costs Associated With Newly Diagnosed Type 1 Diabetes in Children With Commercial Health Plan or Medicaid Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • EE175 Economic Burden of Pneumococcal Disease Among US Children — A Review of Cost-Effectiveness Analyses of Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • PCR137 Within-Trial Interviews to Contextualize the Patient Experience and Supplement Clinical Outcomes Assessments in a Pivotal Trial of a Newly Described, Fatal and Ultra-Rare Pediatric Disease

    Jun 1, 2024, 00:00

  • MSR13 What Most Concerns Patients about the Impact of Diabetes and Its Treatment on Their Ability to Drive?

    Jun 1, 2024, 00:00

  • MT33 Study Design Considerations for Digital Assessments in Parkinson’s Disease Clinical Trials

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • MT35 Budget Impact Analysis of a Digital Intervention for Disease Management in Type 2 Diabetes

    Jun 1, 2024, 00:00

  • PCR71 Assessing Adherence to SGLT2 Inhibitor Add-on to Metformin Therapy in Chinese T2DM Patients: A Real-World Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • P47 GPT: The Next Frontier in Health Economic Modeling?

    Jun 1, 2024, 00:00

  • EPH37 Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults

    Jun 1, 2024, 00:00

  • HTA29 Improving Patient Access to New Health Interventions: Introduction of HTA for Medical Devices in Ukraine According to the Roadmap

    Jun 1, 2024, 00:00

  • CO29 Bruton's Tyrosine Kinase Inhibitors in B-Cell Lymphoma and Risk of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2024, 00:00

  • PCR163 Comparing Compliance By Race and Ethnicity for Schizophrenia Patients on Oral or Long-Acting Injectable Antipsychotics

    Jun 1, 2024, 00:00

  • EE143 Estimating the Cost and Efficiency of Differentiated Direct-to-Pharmacy PrEP Refill Model in Kenya

    Jun 1, 2024, 00:00

  • EE526 Predictors of Annual Eyewear Expenditures in the United States

    Jun 1, 2024, 00:00

  • HTA7 Access to Pan-Tumor Therapies in Oncology – Do US Patients Have an Advantage?

    Jun 1, 2024, 00:00

  • EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective

    Jun 1, 2024, 00:00

  • HSD24 Impact of Telehealth on Health-Related Quality of Life in Depression: A Medical Expenditure Panel Survey Study

    Jun 1, 2024, 00:00

  • RWD10 Annual Health Insurance Treatment Cost of Female Infertility of Another Origin Based on Routinely Collected Financing Data between 2010-2019

    Jun 1, 2024, 00:00

  • HSD98 Benefits and Barriers to Same-Day Long-Acting Reversible Contraceptive Insertion: Evidence and Its Implications from US Settings

    Jun 1, 2024, 00:00

  • RWD17 Evaluating the Use of Antipsychotic Drug and Incidence of Stroke Among Patients With Dementia in the USA

    Jun 1, 2024, 00:00

  • OP19 Addressing RWE Challenges in Real-Time: The ‘Clean Room Committee’ Approach Works to Handle Research Hurdles without Bias

    Jun 1, 2024, 00:00

  • HTA14 Payer Perspectives on the Use of ICER Evidence Reports Over the Past 24 Months

    Jun 1, 2024, 00:00

  • PCR176 Preferences for a Combination Influenza and COVID-19 Vaccine: Results from a Threshold Technique Study with Consumers in the United Kingdom

    Jun 1, 2024, 00:00

  • PCR86 Depression Severity Among Pregnant Patients By Antidepressant Use during Pregnancy

    Jun 1, 2024, 00:00

  • HSD127 Inappropriate Prescribing and Intent to Change Associated With Academic Detailing

    Jun 1, 2024, 00:00

  • EPH193 Validated Case-Identifying Algorithms Using Canadian Administrative Health Data: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • RWD47 Epidemiology of Epidermolysis Bullosa in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • CO34 Glucagon-like Peptide-1 (GLP-1) Receptor Agonists - Efficacy, Safety, and Cost-Effectiveness in Obesity Management: A Systematic Review

    Jun 1, 2024, 00:00

  • RWD48 Economic Burden Associated With Sobriety Restrictions to Direct-Acting Antiviral Access Among Medicaid Patients With Hepatitis C Virus: A Retrospective Analysis of Claims from States With and Without Restrictions

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • CO177 The Effect of Newly Approved Obesity Medications on Cardiovascular Complications

    Jun 1, 2024, 00:00

  • CO6 Clinical Characterization of Patients with Wilson Disease (WD) Using Performance and Qulaitative Measures

    Jun 1, 2024, 00:00

  • EE68 A UK Cost-Utility Analysis of Ferric Carboxymaltose Versus Ferric Derisomaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease: Incorporation of Fracture Data

    Jun 1, 2024, 00:00

  • HSD108 Impacts of Long-Term Prescription Policy on Primary Care Utilization and Costs Among Hypertensive Patients in China: A Difference-in-Differences Analysis

    Jun 1, 2024, 00:00

  • PCR54 Monitoring Health-Related Quality of Life Following Dietary Supplementation With Folic Acid, Vitamin B12, and Vitamin D3 in Patients Diagnosed With Parkinson Disease in Romania

    Jun 1, 2024, 00:00

  • CO4 The Burden of Illness of Treatment-Induced Vasomotor Symptoms in Patients With Breast Cancer: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE512 Fluticasone Furoate/Umeclidinium/Vilanterol Vs Open Triple Therapy for Treating Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from a Brazilian Public Healthcare Perspective: A Budget Impact Analysis

    Jun 1, 2024, 00:00

  • EPH138 Pneumococcal Vaccine Trends Among Older Adults in the United States from 2008 to 2022

    Jun 1, 2024, 00:00

  • EE273 Impact of Mental Health Screening Access on Incremental Cost Estimates Among Patients with Postpartum Depression

    Jun 1, 2024, 00:00

  • MSR8 Validating the Time-Use Algorithm To Estimate Productivity Loss in Persons With Multiple Sclerosis

    Jun 1, 2024, 00:00

  • P36 Unsupported Policy Information? The Institute for Clinical and Economic Review's Unsupported Price Increase Reports

    Jun 1, 2024, 00:00

  • RWD115 Is More Always Better? a Real-World Data Analysis of Hemoglobin A1C Data in Patients with Diabetes

    Jun 1, 2024, 00:00

  • RWD1 To Investigate Gender and Racial Disparities in the Resource Utilization of Patients With Lung Diseases in the US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • EE12 Hypertension-Associated Medical Expenditures Among Privately Insured US Individuals Aged 18 to 64 Years in 2021

    Jun 1, 2024, 00:00

  • HTA10 Unveiling the Impact of Spironolactone in Women With PCOS: Beyond Its Anti-Androgen Properties - Insights From a Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • HPR139 Examining the Intersectionality of Race, Ethnicity, and Social Vulnerabilities in Predicting Severe Maternal Morbidities Among Blue Cross and Blue Shield of Louisiana Mothers

    Jun 1, 2024, 00:00

  • EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon

    Jun 1, 2024, 00:00

  • EE451 Advancing Economic Evaluation Models in Colorectal Cancer Screening: A Comprehensive Methodological Review

    Jun 1, 2024, 00:00

  • EE360 Association Between Public Health Partnership and Telehealth Infrastructure and Medicare Cost and Disparities Among Patients With Depression

    Jun 1, 2024, 00:00

  • PCR77 Postoperative Utilization of Other Orthopedic Services Adversely Affects Patient Reported Outcomes After Total Hip Arthroplasty

    Jun 1, 2024, 00:00

  • EPH140 Comparative Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparins in Cancer Associated Thrombosis

    Jun 1, 2024, 00:00

  • MT18 Public Perspectives on Emerging Multi-Cancer Early Detection (MCED) Tests: A Qualitative Study

    Jun 1, 2024, 00:00

  • EE498 What Are the Total Costs of Comprehensive Outpatient Management of Carpal Tunnel and Trigger Finger Using Time Driven Activity Based Costing Models?

    Jun 1, 2024, 00:00

  • RWD35 Assessing Pharmacoequity in PARPi Therapy Utilization and Outcomes in Ovarian Cancer Patients: Insights From Real-World Evidence

    Jun 1, 2024, 00:00

  • RWD98 Real-World Management of Prurigo Nodularis: Epidemiological and Comorbidity Data in China

    Jun 1, 2024, 00:00

  • RWD92 Contemporary Trends in Treatment Intensification for Men With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in 5 European Countries: Results From Patient Chart Reviews

    Jun 1, 2024, 00:00

  • EPH25 Maternal Sexually Transmitted Infection Trends and Characteristics in the United States: 2018-2022

    Jun 1, 2024, 00:00

  • EPH86 Association of Long-COVID with Depression Among Adults in the United States

    Jun 1, 2024, 00:00

  • EE348 Optimizing Economic Modelling Approaches in Health Disparities Research: Essential Insights

    Jun 1, 2024, 00:00

  • PCR95 Are Patient-Reported Outcomes of Advanced Therapies Adequately Measured in the Real-World Settings in Ulcerative Colitis?

    Jun 1, 2024, 00:00

  • A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques

    Jun 1, 2024, 00:00

  • EE235 Health Care Related Costs of Treatment Delay Among Medicare Beneficiaries Diagnosed With Colon Cancer

    Jun 1, 2024, 00:00

  • EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • PCR10 Psychometric Evaluation and Estimation of Meaningful Change Thresholds of Patient-Reported Outcome Measures in Chronic Inducible Cold Urticaria

    Jun 1, 2024, 00:00

  • EE455 Cost-Effectiveness Analysis of Elacestrant in ER+/HER2- Advanced Breast Cancer Patient from US Payer Perspective

    Jun 1, 2024, 00:00

  • HTA65 How Does Conditional Regulatory Approval Affect the Reimbursement of Drugs in Canada?

    Jun 1, 2024, 00:00

  • HTA56 ICER Vs NICE – What Are Your Key Considerations for Health Technology Assessments for Rare Disease Therapies? Insights from a Review of Completed Assessments (2017-PRESENT)

    Jun 1, 2024, 00:00

  • HSD7 Territorial Inequalities in the Number of Cases Related to Benign Gynecological Disorders in Hungary

    Jun 1, 2024, 00:00

  • EE379 Assessing Trends in the Distribution of Prescription Claim Payments (2011-2021) and Implications for Retail Pharmacies

    Jun 1, 2024, 00:00

  • PCR79 Applying Conjoint Analysis to Explore the Preference of People in Choosing Self-Pay Health Check-up Services

    Jun 1, 2024, 00:00

  • EE59 Advancing Value of Information Methods: Does Conducting Further Research Directly Translate Into Changes in Clinical Practice, or Do Implementation Rates of Interventions Depend on the Levels and Types of Information Generated?

    Jun 1, 2024, 00:00

  • MT3 US Payer Management of Digital Health Technologies: Recent Updates and a Glimpse into the Future

    Jun 1, 2024, 00:00

  • PCR224 Development and Validation of a Tool to Predict Short Term Opioid Overdose Risk after Acquiring a Prescribed Controlled Substance

    Jun 1, 2024, 00:00

  • MSR6 Machine Learning Insights Into COVID-19 Variant Spread Across US Regions

    Jun 1, 2024, 00:00

  • EPH154 Impact of COVID-19 Response on Primary Care Utilization

    Jun 1, 2024, 00:00

  • RWD19 Prescription and Reimbursement Patterns of Apixaban Post Launch: Inquiry into US Closed Claims Data for Association with Disease Severity

    Jun 1, 2024, 00:00

  • RWD142 A Retrospective Analysis of Impact of Triptans and CGRP on Monthly Migraine Days (MMD) in Migraine Patients in the USA

    Jun 1, 2024, 00:00

  • EE444 Target Trial Emulation with Real-World Data to Determine the Population-Level Cost-Effectiveness of Multi-Gene Panel Sequencing for Advanced Melanoma

    Jun 1, 2024, 00:00

  • SA8 Methodological Approaches to Compare Treatment Options for Chronic Hepatitis D: An Early Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR27 Discrete Choice Experiment (DCE) Methodology Associated With a Multi-Phase Patient/Caregiver Preference Study in Growth Hormone Deficiency (GHD)

    Jun 1, 2024, 00:00

  • EPH208 Prevalence and Average Annual Percent Change of Potentially Inappropriate Medication Use in Older Adults before and during the COVID-19 National Emergency

    Jun 1, 2024, 00:00

  • HTA77 PICO Consolidation in European HTA Scoping: Examining PICO Variations in Oncology Drugs in the Context of the European Joint Clinical Assessment

    Jun 1, 2024, 00:00

  • RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice

    Jun 1, 2024, 00:00

  • EPH179 Patterns of Glucocorticoid Use Among Persons with Systemic Lupus Erythematosus (SLE) over Fifteen Years

    Jun 1, 2024, 00:00

  • HSD72 Baseline A1C and BMI Trends for People with Type 2 Diabetes Receiving First-Time GLP-1 Ra Prescriptions

    Jun 1, 2024, 00:00

  • Health Service Delivery Process of Care

    Jun 1, 2024, 00:00

  • MT45 Analytical Performance, Quality of Life and Costs Related to Allergy Testing: Results from Two Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • OP5 Drug Launches Reflect Overall Company Performan Analysis Uncovers Lessons That Large Pharmaceutical Companies Could Glean from Their Smaller Rivals’ Drug Launch Strategies

    Jun 1, 2024, 00:00

  • PCR261 Adherence to Endocrine Therapies Among Women With Non-Metastatic Breast Cancer in Developing Countries

    Jun 1, 2024, 00:00

  • PCR222 Comparison of Recanalisation Therapies in Terms of Quality of Life in Ischaemic Stroke Patients in Hungary

    Jun 1, 2024, 00:00

  • EE339 The Biosimilars’ Economic Evaluation in Contrast With Judicializations’ Economic Impacts of the Pharmaceutical Assistance in Brazil

    Jun 1, 2024, 00:00

  • PCR232 Do QALYs Discriminate Against the Elderly?

    Jun 1, 2024, 00:00

  • MT31 The Role of Parental Self-Efficacy, Capability Well-Being and Electronic Health Literacy in Pediatric Diabetes Management: Insights from a Longitudinal Analysis of Glucose Sensor Data

    Jun 1, 2024, 00:00

  • HTA79 Navigating the Clinical Effectiveness Challenges for Orphan Drug Assessments: A NCPE Review

    Jun 1, 2024, 00:00

  • EE114 A Systematic Review of Cost-Effectiveness Analyses of Gene Therapy Treatments for Hemophilia Type A and B

    Jun 1, 2024, 00:00

  • PCR210 Impact of Advanced/Metastatic Non–Small Cell Lung Cancer (A/MNSCLC) on Patients in the US and UK: Survey Results

    Jun 1, 2024, 00:00

  • EE167 Cost-Effectiveness Evaluations of CAR-T Cell Therapies By Health Technology Assessment Agencies

    Jun 1, 2024, 00:00

  • PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • EE422 “This Isn’t a Life”: An Analysis of EQ-5D in a Cohort of Individuals with Long COVID Symptoms

    Jun 1, 2024, 00:00

  • EE453 Research and Clinical Delivery Costs of a Mobile Health Approach for Hypertension Management in Uncontrolled Hypertensive African Americans: A Cost Analysis

    Jun 1, 2024, 00:00

  • CO149 Comparative Examination of Performance Metrics in Football and Handball Players within Controlled Laboratory Environments

    Jun 1, 2024, 00:00

  • EE449 Cost-Effectiveness Thresholds Around the World: How Brazil Positions Itself Compared to Other Countries

    Jun 1, 2024, 00:00

  • HPR90 Equity Effects of Public Health Insurance on Hypertension in Peru: Insights from a Panel Analysis of the Peruvian Demographic and Health Survey 2013-2019

    Jun 1, 2024, 00:00

  • EE402 Comparing the Expenditure and Health-Related Quality of Life between SGLT2 Inhibitors and GLP-1 Agonists

    Jun 1, 2024, 00:00

  • EE349 Cost-Effectiveness of First-Line Treatment With Pembrolizumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer (CRC) in the United States Based on 5-Year Follow-up Data

    Jun 1, 2024, 00:00

  • HSD77 Prescription Patterns for COVID-19 before the Availability of Antiviral Drugs Using the National Database of Health Insurance Claims in Japan

    Jun 1, 2024, 00:00

  • CO119 Indirect Treatment Comparison and Cost-Minimization Analysis between Riociguat and Selexipag to WHO Functional Class III Pulmonary Arterial Hipertension (PAH) Patients

    Jun 1, 2024, 00:00

  • CO47 A Novel Approach to Estimating the Risk of Harm Due to Drug-Drug Interactions: An Exemplary Model With Common Mediations That Interact With Oral Anticoagulants

    Jun 1, 2024, 00:00

  • EE90 Diagnostic Yield and Downstream Lung Cancer Treatment Revenue From Shape-Sensing Robotic-Assisted Bronchoscopy Compared to Transthoracic Needle Aspiration Biopsy

    Jun 1, 2024, 00:00

  • HTA30 Evolution of Health Technology Assessment for Rare Diseases and Its Impact on Access

    Jun 1, 2024, 00:00

  • EE313 Economic Impact of Cancer Related to Human Papilloma Virus in Ecuador

    Jun 1, 2024, 00:00

  • EPH162 Characterizing Antimicrobial Resistance Post-Hospitalization: A Retrospective Analysis Using Administrative Claims Data

    Jun 1, 2024, 00:00

  • SA16 Estimating Infant Date of Birth in Administrative Claims Databases: A Comparison of Exact Date of Birth and Date of Birth Proxies

    Jun 1, 2024, 00:00

  • HTA33 Lung Cancer Health Technology Assessments Trends in Argentina, Brazil, Colombia, and Mexico

    Jun 1, 2024, 00:00

  • MSR11 Can We Predict the Impact of the Differential Sensitivity of Health-Related Quality of Life (HRQoL) Instruments on the Valuation of Health State Changes?

    Jun 1, 2024, 00:00

  • EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2024, 00:00

  • PCR130 Comparison of the Quality of Life and Socio-Demographic Characteristics of Women with Physical Disabilities

    Jun 1, 2024, 00:00

  • OP10 The Meteoric Rise of RWE and HEOR: Operating With Efficiency and Fostering Innovation Between the Two Groups

    Jun 1, 2024, 00:00

  • EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA

    Jun 1, 2024, 00:00

  • PCR263 Health Utility Decrement of Treatment-Related Attributes for Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • HTA5 Examining the Impact of Eams on NICE Recommendations over the Past Four Years

    Jun 1, 2024, 00:00

  • EE77 Non-Quality Costs of Unsafe Healthcare in a Hospital Institution

    Jun 1, 2024, 00:00

  • RWD139 Enhancing Public Health Through Timely Detection: Assessing the Value of Real-World Evidence With a Cardiovascular Defibrillator Leads Case Study

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20 (current)
  • »